The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Table of Contents
1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Cancer Drugs Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Chemotherapy
2.1.2 Targeted Therapy
2.1.3 Immunotherapy
2.1.4 Hormonal Therapy (Biologic Therapy)
2.1.5 Others
2.2 Overall Market Performance(Value)
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy
2.2.4 Hormonal Therapy (Biologic Therapy)
2.2.5 Others
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Blood Cancer
3.1.2 Breast Cancer
3.1.3 Gastrointestinal Cancer
3.1.4 Prostate Cancer
3.1.5 Respiratory/Lung Cancer
3.1.6 Other Cancers
4 Manufacturers Profiles/Analysis
4.1 Roche
4.1.1 Roche Profiles
4.1.2 Roche Product Information
4.1.3 Roche Cancer Drugs Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 Roche SWOT Analysis
4.2 Novartis
4.2.1 Novartis Profiles
4.2.2 Novartis Product Information
4.2.3 Novartis Cancer DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Novartis SWOT Analysis
4.3 Celgene
4.3.1 Celgene Profiles
4.3.2 Celgene Product Information
4.3.3 Celgene Cancer DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Celgene SWOT Analysis
4.4 Bristol-Myers Squibb
4.4.1 Bristol-Myers Squibb Profiles
4.4.2 Bristol-Myers Squibb Product Information
4.4.3 Bristol-Myers Squibb Cancer DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.4.4 Bristol-Myers Squibb SWOT Analysis
4.5 Amgen
4.5.1 Amgen Profiles
4.5.2 Amgen Product Information
4.5.3 Amgen Cancer DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.5.4 Amgen SWOT Analysis
4.6 Johnson & Johnson
4.6.1 Johnson & Johnson Profiles
4.6.2 Johnson & Johnson Product Information
4.6.3 Johnson & Johnson Cancer DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.6.4 Johnson & Johnson SWOT Analysis
4.7 Pfizer
4.7.1 Pfizer Profiles
4.7.2 Pfizer Product Information
4.7.3 Pfizer Cancer DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.7.4 Pfizer SWOT Analysis
4.8 Takeda
4.8.1 Takeda Profiles
4.8.2 Takeda Product Information
4.8.3 Takeda Cancer DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.8.4 Takeda SWOT Analysis
4.9 Eli Lilly
4.9.1 Eli Lilly Profiles
4.9.2 Eli Lilly Product Information
4.9.3 Eli Lilly Cancer DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.9.4 Eli Lilly SWOT Analysis
4.10 AstraZeneca
4.10.1 AstraZeneca Profiles
4.10.2 AstraZeneca Product Information
4.10.3 AstraZeneca Cancer DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.10.4 AstraZeneca SWOT Analysis
4.11 Astellas
4.12 Merck & Co.
4.13 Sanofi
4.14 Bayer
4.15 Biogen Idec
4.16 Eisai
4.17 Teva
4.18 Otsuka
4.19 Merck KGaA
4.20 Ipsen
4.21 AbbVie
4.22 Gilead Sciences
5 Market Performance for Manufacturers
5.1 Global Cancer Drugs Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global Cancer Drugs Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global Cancer Drugs Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global Cancer Drugs Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Cancer Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Cancer Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Cancer Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Cancer Drugs Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Cancer Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA Cancer Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA Cancer Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA Cancer Drugs Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Cancer Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe Cancer Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe Cancer Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe Cancer Drugs Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Cancer Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan Cancer Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan Cancer Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan Cancer Drugs Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Cancer Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea Cancer Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea Cancer Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea Cancer Drugs Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Cancer Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India Cancer Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India Cancer Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India Cancer Drugs Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Cancer Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia Cancer Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia Cancer Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia Cancer Drugs Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Cancer Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America Cancer Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America Cancer Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America Cancer Drugs Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global Cancer Drugs Market Assessment by Regions (2014-2020)
7.1 Global Cancer Drugs Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global Cancer Drugs Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global Cancer Drugs Price (USD/Unit) by Regions 2014-2020
7.4 Global Cancer Drugs Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global Cancer Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China Cancer Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA Cancer Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe Cancer Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan Cancer Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea Cancer Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India Cancer Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Cancer Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Cancer Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Blood Cancer Industry
11.2 Breast Cancer Industry
11.3 Gastrointestinal Cancer Industry
11.4 Prostate Cancer Industry
11.5 Respiratory/Lung Cancer Industry
11.6 Other Cancers Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global Cancer Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global Cancer Drugs Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America Cancer Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Chemotherapy
12.2.3 Targeted Therapy
12.2.4 Immunotherapy
12.2.5 Hormonal Therapy (Biologic Therapy)
12.2.6 Others
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Blood Cancer
12.3.3 Breast Cancer
12.3.4 Gastrointestinal Cancer
12.3.5 Prostate Cancer
12.3.6 Respiratory/Lung Cancer
12.3.7 Other Cancers
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Cancer Drugs Price (USD/Unit) Trend 2021-2026
12.4.2 Global Cancer Drugs Gross Profit Trend 2021-2026
13 Conclusion
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 221 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Services | Pages : 123 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Electronics | Pages : 300 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Automotive | Pages : 280 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 260 |
We will be happy to help you find what you need. Please call us or write to us: